eli lilly clinical trials tirzepatide Lilly's weight loss drug Zepbound found to reduce sleep apnea, company says F.D.A. Approves New Obesity Drug

While not a widely recognised side effect of GLP-1 medications, emerging evidence suggests potential links through neuroinflammation, altered pain modulation, and metabolic effects on nerve function

Doctor visits every 3 months with the option to reach out anytime through the app

The program is designed to provide noticeable results without extensive lifestyle changes, making it a convenient option for those seeking effective weight management

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

Biesterveld BE, Wakam GK, Kemp MT, Williams AM, Shamshad A, OConnell RL, et al